Release Date: 19/02/18 15:52 Summary: Change in substantial holding from CBA Price Sensitive: No Download Document 184.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%